Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Dianthus Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −18 vs. Q3 2022
- Shares held
- 28.1M
- −18.5M (−39.6%) vs. Q3 2022
- Total value
- $11.1M
- −$54.6M (−83.1%) vs. Q3 2022
- New holders
- 7
- 16 more added
- Sold out
- 25
- 15 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 703 | $0 | 0.00% | −2,486−78.0% | Reduced |
| Umb Bank N A | 742 | $0 | 0.00% | 00.0% | Unchanged |
| Pension & Wealth Management Advisors, Inc. | 10 | $4 | 0.00% | +10 | New |
| Institutional & Family Asset Management, LLC | 50 | $20 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 325 | $128 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 737 | $291 | 0.00% | +36+5.1% | Added |
| Wells Fargo & Company | 761 | $300 | 0.00% | −1,484−66.1% | Reduced |
| Barclays PLC | 5,321 | $2.10K | 0.00% | −1,926−26.6% | Reduced |
| Belpointe Asset Management LLC | 5,500 | $2.17K | 0.00% | +5,500 | New |
| BNP Paribas Arbitrage, SA | 5,735 | $2.27K | 0.00% | +544+10.5% | Added |
| Bank of America Corp | 7,034 | $2.78K | 0.00% | +6,863+4,013.5% | Added |
| Royal Bank of Canada | 5,372 | $3.00K | 0.00% | −13−0.2% | Reduced |
| Citadel Advisors LLC | 7,826 | $3.09K | 0.00% | −32,433−80.6% | Reduced |
| Rathbone Brothers plc | 10,000 | $3.95K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 12,237 | $4.83K | 0.00% | +12,237 | New |
| Bank of New York Mellon Corp | 16,049 | $6.34K | 0.00% | −35−0.2% | Reduced |
| Ergoteles LLC | 21,800 | $8.61K | 0.00% | −93,322−81.1% | Reduced |
| Charles Schwab Investment Management Inc | 27,369 | $10.8K | 0.00% | 00.0% | Unchanged |
| National Asset Management, Inc. | 28,000 | $11.1K | 0.00% | +28,000 | New |
| Fiduciary Trust Co | 30,555 | $12.1K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 34,090 | $13.5K | 0.00% | +34,090 | New |
| Tower Research Capital LLC (TRC) | 38,808 | $15.0K | 0.00% | +26,219+208.3% | Added |
| Goldman Sachs Group Inc | 38,059 | $15.0K | 0.00% | −73,702−65.9% | Reduced |
| Cheyne Capital Management (UK) LLP | 47,170 | $18.6K | 0.03% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 75,806 | $29.9K | 0.00% | −10,825−12.5% | Reduced |
| Morgan Stanley | 79,703 | $31.5K | 0.00% | +64,288+417.0% | Added |
| Northern Trust Corp | 86,611 | $34.2K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 120,798 | $46.0K | 0.00% | +25,756+27.1% | Added |
| Thrivent Financial for Lutherans | 129,395 | $47.0K | 0.00% | +129,395 | New |
| State Street Corp | 139,207 | $55.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 152,984 | $60.0K | 0.00% | 00.0% | Unchanged |
| Harbor Capital Advisors, Inc. | 160,912 | $63.6K | 0.06% | −3,441−2.1% | Reduced |
| Leonteq Securities AG | 180,000 | $71.1K | 0.00% | +180,000 | New |
| Two Sigma Investments, LP | 186,125 | $73.5K | 0.00% | +55,066+42.0% | Added |
| Credit Suisse AG | 193,500 | $76.4K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 212,200 | $83.8K | 0.00% | +65,000+44.2% | Added |
| Bessemer Group Inc | 237,292 | $94.0K | 0.00% | +150.0% | Added |
| Two Sigma Advisers, LP | 250,500 | $98.9K | 0.00% | −36,900−12.8% | Reduced |
| Harvard Management Co Inc | 332,610 | $131.4K | 0.02% | 00.0% | Unchanged |
| RBF Capital, LLC | 341,422 | $135.0K | 0.01% | −30,000−8.1% | Reduced |
| Bleichroeder LP | 346,631 | $136.9K | 0.03% | −137,769−28.4% | Reduced |
| Geode Capital Management, LLC | 357,690 | $141.0K | 0.00% | +7,254+2.1% | Added |
| Integral Health Asset Management, LLC | 416,000 | $164.3K | 0.04% | +39,000+10.3% | Added |
| Hellman Jordan Management Co Inc | 441,125 | $174.0K | 0.30% | +259,161+142.4% | Added |
| BlackRock Inc. | 463,036 | $182.9K | 0.00% | −274,851−37.2% | Reduced |
| Laurion Capital Management LP | 582,300 | $230.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 587,922 | $232.0K | 0.00% | +183,071+45.2% | Added |
| Adage Capital Partners GP, L.L.C. | 868,650 | $343.1K | 0.00% | +50,000+6.1% | Added |
| Vanguard Group Inc | 1,964,238 | $775.9K | 0.00% | +8060.0% | Added |
| Millennium Management LLC | 2,313,552 | $914.0K | 0.00% | +218,210+10.4% | Added |
| Deep Track Capital, LP | 3,000,000 | $1.19M | 0.05% | −2,359,000−44.0% | Reduced |
| Alphabet Inc. | 3,339,138 | $1.34M | 0.08% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 3,476,536 | $1.37M | 0.17% | 00.0% | Unchanged |
| TRV GP IV, LLC | 6,758,204 | $2.67M | 1.14% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −3,588,081−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −3,308,899−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −2,250,953−100.0% | Sold out |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −2,124,122−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −1,304,946−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −1,286,230−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −1,019,091−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −705,217−100.0% | Sold out |
| Palo Alto Investors LP | 0 | $0 | 0.00% | −432,300−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −320,000−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −171,729−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −130,756−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −20,414−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,954−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −12,173−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,671−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −8,264−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,648−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −570−100.0% | Sold out |
| Axiom Investment Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −551−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −106−100.0% | Sold out |